Trials / Sponsors / Invivyd, Inc.
Invivyd, Inc.
Industry · 7 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Active Not Recruiting | Study of VYD2311 for the Prevention of COVID-19 COVID-19 | Phase 3 | 2026-01-08 |
| Active Not Recruiting | A Study of the Investigational Monoclonal Antibody, VYD2311, in Healthy Participants COVID-19 | Phase 1 | 2024-08-28 |
| Completed | A Study to Investigate the Prevention of COVID-19 WithVYD222 in Adults with Immune Compromise and in Participa COVID-19, SARS-CoV-2 | Phase 3 | 2023-09-08 |
| Completed | A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of the Monoclonal Antibody VYD222 in Hea COVID-19 | Phase 1 | 2023-03-28 |
| Terminated | Evaluation of ADG20 for the Treatment of Mild or Moderate COVID-19 COVID-19 | Phase 2 / Phase 3 | 2021-07-26 |
| Terminated | Evaluation of ADG20 for the Prevention of COVID-19 COVID-19 | Phase 2 / Phase 3 | 2021-04-27 |
| No Longer Available | Provide Pre-approval Single-patient Expanded Access (Compassionate Use) of VYD222 for Patients With Symptomati COVID-19 | — | — |